Recent investigations in the USA estimated that over three percent of the African American population had a specific TTR mutation that significantly increases the risk of TTR amyloidosis [7], while approximately eight percent of patients with suspected cardiac amyloidosis having pathogenic TTR mutations [8]. This evidence concerns the gene TTR and cardiac amyloidosis.